
Telmitos Trio 40mg/5mg/12.5mg Tablet
Marketer
Atos Lifesciences Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telmitos Trio 40mg/5mg/12.5mg Tablet
Triomune HT 40mg/5mg/12.5mg tablets combine three medications to manage hypertension when other treatments prove insufficient. This formulation effectively lowers elevated blood pressure, thereby significantly reducing the risk of future strokes and heart attacks. Triomune HT can be taken with or without food, with dosage tailored to individual needs and response. Consistent daily timing is recommended. Continuous use, as directed by your physician, is crucial; discontinuation may increase stroke or heart attack risk. The medication includes a diuretic, increasing urination, so avoid late-evening doses (within four hours of bedtime). Regular use, even during symptom-free periods, maximizes benefits, as hypertension often presents without noticeable symptoms. Common side effects may include headache, dizziness, lethargy, altered taste perception, flu-like symptoms, diarrhea, and sinus inflammation. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to mitigate potential dryness, thirst, or muscle weakness. Prior to commencing treatment, inform your doctor of any kidney or liver conditions, pregnancy, breastfeeding, or other medications, particularly those for heart conditions or hypertension. Regular monitoring of blood pressure, kidney function, electrolyte balance, and blood glucose levels is essential to optimize treatment efficacy and safety.
Primary Ingredients of Telmitos Trio 40mg/5mg/12.5mg Tablet
There is no text provided to rephrase.
Uses of Telmitos Trio 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Telmitos Trio 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Telmitos Trio 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.
Common Side effects of Telmitos Trio 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telmitos Trio 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Telmitos Trio 40mg/5mg/12.5mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.
How Telmitos Trio 40mg/5mg/12.5mg Tablet works:
Each Telmitos Trio 40mg/5mg/12.5mg tablet combines telmisartan, amlodipine, and hydrochlorothiazide to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both act to dilate blood vessels, reducing blood pressure. Hydrochlorothiazide, a diuretic, promotes fluid excretion, lowering blood volume and further easing vascular constriction. This combined effect leads to sustained blood pressure control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Telmitos Trio 40mg/5mg/12.5mg Tablet use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Use of Telmitos Trio 40mg/5mg/12.5mg tablets is contraindicated during pregnancy due to established risk to the fetus. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingUNSAFE
The combination drug Telmitos Trio (40mg/5mg/12.5mg tablets) is contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by side effects of Telmitos Trio 40mg/5mg/12.5mg Tablets. These tablets may induce dizziness, headaches, nausea, or fatigue, potentially impacting concentration and driving safety.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmitos Trio 40mg/5mg/12.5mg tablets, potentially requiring dosage modification. Physician consultation is advised. Telmitos Trio 40mg/5mg/12.5mg tablets are generally unsuitable for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Telmitos Trio 40mg/5mg/12.5mg tablets, as dosage modification may be necessary. Medical advice is recommended.
What if you forget to take Telmitos Trio 40mg/5mg/12.5mg Tablet :
Should you forget a Telmitos Trio 40mg/5mg/12.5mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmitos Trio 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | HEART |
